Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases.

NCT03803241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: CD133+ infusion
OTHER: portal vein embolization

Sponsor

Hospital San Carlos, Madrid